Yayınlar & Eserler

Yayın Ağı
Makaleler 33
Tümü (33)
SCI-E, SSCI, AHCI (30)
SCI-E, SSCI, AHCI, ESCI (33)
ESCI (3)
Scopus (32)
TRDizin (3)

1. 4-{3-[(Pyridin-4-ylmethyl)amino]-[1,2,4]triazolo[4,3-b][1,2,4]triazin-6-yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator

Khatir Z. Z., Di Sotto A., Percaccio E., TÜYLÜ KÜÇÜKKILINÇ Z. T., ERCAN A., Chippindale A. M., et al.
Archiv der Pharmazie , 2024 (SCI-Expanded, Scopus) identifier identifier identifier

2. Phenelzine protects against acetaminophen induced apoptosis in HepG2 cells

TÜYLÜ KÜÇÜKKILINÇ Z. T., ERCAN A.
Drug and Chemical Toxicology , cilt.47, sa.1, ss.81-89, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

3. Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines

Şenol Y., KAPLAN O., VARAN C., Demirtürk N., Öncül S., Fidan B. B., et al.
Journal of Drug Delivery Science and Technology , cilt.79, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

4. Effects of single or combined exposure to bisphenol A and mono(2-ethylhexyl)phthalate on oxidant/antioxidant status, endoplasmic reticulum stress, and apoptosis in HepG2 cell line

ÖZKEMAHLI K. G., ERKEKOĞLU Ü. P., ERCAN A., ZEYBEK N. D., YERSAL N., GÜMÜŞEL B.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH , cilt.30, ss.12189-12206, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

5. Plasma irisin and metabolomic response differ between concentric and isometric exercise Effets différents de l'exercice concentrique et de l'exercice isométrique sur l'irisine plasmatique et la réponse métabolomique

KARA Ö. S., ERCAN A., ÇELEBİER M., KAPLAN O., ÖNCÜL S., KORKUSUZ F.
Science and Sports , cilt.37, sa.7, ss.610-617, 2022 (SCI-Expanded, Scopus) identifier identifier

6. A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU

Akkin S., VARAN G., AKSÜT D., Malanga M., ERCAN A., ŞEN M., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.623, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

7. Q-tof lc/ms-based untargeted metabolomics approach to evaluate the effect of folate-conjugated cyclodextrins on triple-negative breast cancer cells

Varol I., KAPLAN O., Erdoğar N., Öncül S., Nielsen T. T., ERCAN A., et al.
Current Pharmaceutical Analysis , cilt.17, sa.10, ss.1272-1281, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

8. An investigation of the effect of surface characterization on Saos-2 cell proliferation after coating of titanium alloy surfaces by a selective laser melting process

Olcay E. O., ERCAN A., ÖNCÜL S., Arifagaoglu O., ERSU B.
Surface and Coatings Technology , cilt.422, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

9. Antitumor activity of Ankaferd Blood Stopper (R) on MCF-7 breast cancer: A proteomic approach to ascertain the mechanism of the action

Zeki O. C., NENNİ M., ÇELEBİER M., ÖNCÜL S., ERCAN A., SÜSLÜ İ., et al.
JOURNAL OF HERBAL MEDICINE , cilt.28, 2021 (SCI-Expanded, Scopus) identifier identifier

10. Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular level

ERCAN A., ÇELEBİER M., ÖNCÜL S., VARAN G., KOÇAK E., Benito J. M., et al.
International Journal of Pharmaceutics , cilt.598, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

11. Exposure of Hepatocellular Carcinoma Cells to Ankaferd Blood Stopper (R) Alters Cell Death Signaling Networks Confirmed by Oncoproteomic and Genomic Profiling Studies

NENNİ M., ÖNCÜL S., ERCAN A., ÇELEBİER M., SÜSLÜ İ., HAZNEDAROĞLU İ. C.
CURRENT TRADITIONAL MEDICINE , cilt.7, sa.2, ss.223-235, 2021 (ESCI, Scopus) identifier identifier

12. Recent Approaches to Integrate Multiomics Data on System Biology

ÇELEBİER M., ERCAN A.
CURRENT ANALYTICAL CHEMISTRY , cilt.17, sa.9, ss.1243-1251, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

13. An allomaltol derivative triggers distinct death pathways in luminal a and triple-negative breast cancer subtypes

ERCAN A., ÖNCÜL S., Karakaya G., Aytemir M.
BIOORGANIC CHEMISTRY , cilt.105, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

14. Comparison of cell lysis techniques via q-tof lc/ms

KAPLAN O., ÖNCÜL S., ERCAN A., ÇELEBİER M.
Mass Spectrometry Letters , cilt.11, sa.2, ss.36-40, 2020 (ESCI, Scopus) Sürdürülebilir Kalkınma identifier identifier

15. A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistance

ÖNCÜL S., Karakaya G., Dilsiz Aytemir M., ERCAN A.
Chemical Biology and Drug Design , cilt.94, sa.6, ss.2084-2093, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

16. Synthesis, computational molecular docking analysis and effectiveness on tyrosinase inhibition of kojic acid derivatives

Karakaya G., TÜRE A., ERCAN A., ÖNCÜL S., Aytemir M.
Bioorganic Chemistry , cilt.88, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

17. HGF-1 proliferation on titanium dental implants treated with laser melting technology

Arifagaoglu O., ÖNCÜL S., ERCAN A., Olcay O., ERSU B.
NIGERIAN JOURNAL OF CLINICAL PRACTICE , cilt.22, sa.2, ss.251-257, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

18. Kojic acid derivatives as potential anticancer agents: Synthesis and cytotoxic evaluation on A375 human malignant melanoma cells

Karakaya G., ERCAN A., ÖNCÜL S., Aytemir M.
JOURNAL OF RESEARCH IN PHARMACY , cilt.23, sa.4, ss.596-607, 2019 (ESCI, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

19. Synthesis and anticancer activity of benzimidazole/benzoxazole substituted triazolotriazines in hepatocellular carcinoma

Dadashpour S., Küçükkılınç T. T., ERCAN A., Hosseinimehr S. J., Naderi N., Irannejad H.
Anti-Cancer Agents in Medicinal Chemistry , cilt.19, sa.17, ss.2120-2129, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

20. Synthesis and Cytotoxic Evaluation of Kojic Acid Derivatives with Inhibitory Activity on Melanogenesis in Human Melanoma Cells

KARAKAYA G., ÖNCÜL S., ERCAN A., AYTEMİR M.
Anti-Cancer Agents In Medicinal Chemistry , cilt.18, ss.1-12, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

21. Global omics strategies to investigate the effect of cyclodextrin nanoparticles on MCF-7 breast cancer cells

ERCAN A., ÇELEBİER M., VARAN G., ÖNCÜL S., Nenni M., KAPLAN O., et al.
European Journal of Pharmaceutical Sciences , cilt.123, ss.377-386, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

22. Breast cancer treatment capacity of an allomaltol derivative from the standpoint of apoptosis and multidrug resistance

Oncul S., ERCAN A., Karakaya G., Aytemir M.
FEBS OPEN BIO , cilt.8, ss.298, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

23. Discrimination of the Effects of Doxorubicin on Two Different Breast Cancer Cell Lines on Account of Multidrug Resistance and Apoptosis

ÖNCÜL S., ERCAN A.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.79, sa.4, ss.599-607, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

24. Cholesterol-Targeted Anticancer and Apoptotic Effects of Anionic and Polycationic Amphiphilic Cyclodextrin Nanoparticles

VARAN G., ÖNCÜL S., ERCAN A., BENITO J. M., MELLET C. O., BİLENSOY E.
Journal of Pharmaceutical Sciences , cilt.105, sa.10, ss.3172-3182, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

25. Evaluation of selective human MAO inhibitory activities of some novel pyrazoline derivatives

Salgin-Goksen U., Yabanoglu-Ciftci S., ERCAN A., Yelekci K., UÇAR G., Gokhan-Kelekci N.
JOURNAL OF NEURAL TRANSMISSION , cilt.120, sa.6, ss.863-873, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

26. Pyrazoline based MAO inhibitors: Synthesis, biological evaluation and SAR studies

JAGRAT M., BEHERA J., YABANOGLU S., ERCAN A., UÇAR G., SINHA B. N., et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS , cilt.21, sa.14, ss.4296-4300, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

27. The determination of matrix metalloproteinase 9 activity and gene expression levels in Behcet's disease patients with aneurysmal complications

AKSOY Y., ERCAN A., Dalmizrak O., CANPINAR H., DURMAZLAR S. P. K., BAYAZIT M.
CLINICAL RHEUMATOLOGY , cilt.30, sa.4, ss.515-519, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

28. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors

GOKHAN-KELEKCI N., SIMSEK O. O., ERCAN A., Yelekci K., Sahin Z. S., Isik S., et al.
BIOORGANIC & MEDICINAL CHEMISTRY , cilt.17, sa.18, ss.6761-6772, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

29. Mitochondrial Respiratory Chain Enzyme Activities, mtDNA Variants and Gene Expression Levels in Idiopathic Parkinson's Disease

ERCAN A., KULAKSIZ G., Dalmizrak O., Muftuoglu M., OGUS H., CAVDAR L., et al.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.34, sa.2, ss.97-104, 2009 (SCI-Expanded, Scopus, TRDizin) identifier identifier

30. Pyrazoline-based mycobactin analogues as MAO-inhibitors

Jayaprakash V., Sinha B. N., UÇAR G., ERCAN A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS , cilt.18, sa.24, ss.6362-6368, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

31. Effects of Three Actinic Keratosis Mutations on Apoptosis

ERCAN A., OGUS I. H.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.33, sa.4, ss.197-201, 2008 (SCI-Expanded, TRDizin) Sürdürülebilir Kalkınma identifier

32. Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations

MUFTUOGLU M., ELIBOL B., DALMIZRAK O., Ercan A., KULAKSIZ G., OGUS H., et al.
MOVEMENT DISORDERS , cilt.19, sa.5, ss.544-548, 2004 (SCI-Expanded, Scopus) identifier identifier identifier

33. Simple, high-yield purification of xanthine oxidase from bovine milk

OZER N., MUFTUOGLU M., ATAMAN D., Ercan A., OGUS I.
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS , cilt.39, sa.3, ss.153-159, 1999 (SCI-Expanded, Scopus) identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 26

1. Proteomic Investigation of Ankaferd Hemostat Application on MCF-7 Breast Cancer Cell Line

ZEKİ Ö. C., NENNİ M., ÖNCÜL S., ERCAN A., SÜSLÜ İ., HAZNEDAROĞLU İ. C.
International Multidisciplinary Symposium on Drug Research and Development (DRD), 1 - 03 Temmuz 2019, (Özet Bildiri) Sürdürülebilir Kalkınma

2. A Metabolomic Study to Investigate the Effect of Folate Conjugated Nanoparticles on Triple Negative Breast Cancer Cells

ERCAN A., ÇELEBİER M., varol ı., KAPLAN O., Varan G., ÖNCÜL S., et al.
EUFEPS Annual Meeting 2019 PERSONALIZED MEDICINES,TARGETED THERAPIES,PRECISION DRUG DELIVERY, 6 - 08 Mart 2019, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

3. The effect of polycationic amphiphilic cyclodestrin nanoparticles on mda-mb cancer cells: A metabolomic approach to understand the mechanism

ÇELEBİER M., KAPLAN O., VARAN G., ÖNCÜL S., KOÇAK E., ERCAN A., et al.
12 th International symposium on pharmaceutical sciences, 26 Haziran 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

4. Exploring Cell Death Mechanism In A375 Human Malign Melanoma Cells Upon Treatment A Mannich Base Derivative

ERCAN A., AYTEMİR M.
12th International Symposium on Pharmaceutical Sciences (ISOPS 12th), 26 - 29 Haziran 2018, (Özet Bildiri)

5. Investigation of The Effect of Commercial Herbal Mixture on HepG2 Liver Cancer Cell Line by Proteomic Approach

NENNİ M., ÖNCÜL S., ERCAN A., SÜSLÜ İ., ÇELEBİER M., HAZNEDAROĞLU İ. C.
12th International Symposium on Pharmaceutical Sciences, 26 - 29 Haziran 2018, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

6. Breast Cancer Treatment Capacity of a Allomaltol Derivative from the Standpoint of Apoptosis and Multidrug Resistance

ÖNCÜL S., ERCAN A., KARAKAYA G., AYTEMİR M.
The 43rd FEBS Congress, Prag, Çek Cumhuriyeti, 07 Haziran 2018, ss.1, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

7. GENOMIC AND METABOLOMIC STUDIES OF POLYCATIONIC AMPHIPHILIC CYCLODEXTRIN NANOPARTICLESON HEPG2 CELL LINE

ERCAN A., ÇELEBİER M., Varan G., ÖNCÜL S., KOÇAK E., KAPLAN O., et al.
EUFEPS Annual Meeting 2018 Crossing Barriers for Future Medicines, 24 - 26 Mayıs 2018, (Tam Metin Bildiri)

8. Synthesis of Some New Mannich Bases with Anti-tyrosinase Activity.

AYTEMİR M., KARAKAYA G., ERCAN A., ÖNCÜL S.
2nd International Gazi Pharma Symposium Series (GPSS), 11 - 13 Ekim 2017, (Özet Bildiri)

9. An in vitro investigation of human gingival fibroblast proliferation on dental titanium implants treated with selective laser melting technology

ARİFAĞAOĞLU Ö., ÖNCÜL S., ERCAN A., ERSU B.
26th Annual Scientific Meeting of the European Association for Osseointegration, Madrid, İspanya, 5 - 07 Ekim 2017, cilt.28, ss.26, (Özet Bildiri)

10. Investigation of the Effect of Cyclodextrin Nanoparticles on MCF 7 Breast Cancer Cell Line by Proteomics Approaches

BİLENSOY E., ÇELEBİER M., ERCAN A., NENNİ M., IŞIK G., ÖNCÜL S., et al.
7th BBBB International Conference on Pharmaceutical Sciences, 5 - 07 Ekim 2017, (Tam Metin Bildiri)

11. MCF-7 Breast Cell Proteome Analysis Determination With New UPLC/MS Method

KOÇAK E., ÖNCÜL S., NENNİ M., kaplan o., ÇELEBİER M., SÜSLÜ İ., et al.
Symposium on Drug Research Development, 5 - 07 Ekim 2017, (Özet Bildiri)

12. Screening for Cytotoxic Effects of Chlorokojic Acid Derivatives

AYTEMİR M., Karakaya G., ERCAN A., ÖNCÜL S.
Symposium on Drug Research And Development, 5 - 07 Ekim 2017, (Özet Bildiri)

13. Screening for Cytotoxic Effects of Chkorokojic Acid Derivatives

AYTEMİR M., KARAKAYA G., ERCAN A., ÖNCÜL S.
International Multidisiplinary Symposium on Drug Research Development (DRD2017), 5 - 07 Ekim 2017, (Özet Bildiri) Creative Commons License identifier identifier identifier

14. Cytotoxic Effect of Allomaltol Derivative on A375 Human Malignant Melanoma and MCF7 Breast Cancer Cells

ERCAN A., AYTEMİR M., KARAKAYA G., ÖNCÜL S.
International Multidisiplinary Symposium on Drug Research Development (DRD2017), 5 - 07 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

15. Mild doses of doxorubicin alters apoptoticresponse and cell cycle arrest on both luminalA and triple negative breast cancer cell lines

ÖNCÜL S., ERCAN A.
42nd FEBS Congress, İsrail, 10 - 14 Eylül 2017, cilt.284, ss.286, (Özet Bildiri) Sürdürülebilir Kalkınma

16. Cell Death and Multidrug Resistance in Breast Cancer Cells: Are we Close to Cross the Treshold?

ERCAN A.
2nd Global Insight Conference on Breast Cancer, Roma, İtalya, 4 - 06 Eylül 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

17. CYTOTOXICITY OF A KOJIC ACID DERIVATIVE ON A375 HUMAN MALIGNANT MELANOMA AND HGF1 FIBROBLAST CELLS

AYTEMİR M., KARAKAYA G., ERCAN A., ÖNCÜL S.
10th Joint Meeting On Medicinal Chemistry, Dubrovnik, Hırvatistan, 25 - 28 Haziran 2017, (Özet Bildiri)

18. Evaluation of Cholesterol-Targeted Amphiphilic Cyclodextrin Nanoparticles for Cancer Therapy

VARAN G., ÖNCÜL S., ERCAN A., BENİTO J., MELLET C. O., BİLENSOY E.
Innovation in Medicine Meetings III Congress, 11 - 13 Mayıs 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

19. Glukometre Cihazlarının Ulusal Verifikasyonu

TÜYLÜ KÜÇÜKKILINÇ Z. T., ERCAN A., TANIŞ F., UÇAR G.
İnsülin Direnci Sempozyumu, Türkiye, 22 - 23 Mart 2017, (Özet Bildiri)

20. Assessment of Low Dose Doxorubicin on Apoptosis and Multidrug Resistance in MCF 7 Cells

ERCAN A., ÖNCÜL S.
6. MOKAD, Konya, Türkiye, 27 - 30 Ekim 2016, (Özet Bildiri)

21. Doxorubicin induces multidrug resistance in MDA-MB-231 breast cancer cell line

Oncul S., ERCAN A.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.153, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

22. Demonstration of apoptosis via TUNEL assay and Codon 72 Polymorphism of p53 gene of MCF-7 and MDA-MB-231 cell lines upon treatment of Doxorubicin

Oncul S., ERCAN A.
40th Congress of the Federation-of-European-Biochemical-Societies (FEBS) - The Biochemical Basis of Life, Berlin, Almanya, 4 - 09 Temmuz 2015, cilt.282, ss.270, (Özet Bildiri) identifier

23. Investigation of the relationship between aromatase and seladin 1 in vivo and in vitro

KARAHAN H., LÜLE S., TÜYLÜ KÜÇÜKKILINÇ Z. T., ERCAN A., KELİCEN UĞUR E. P.
SFN (Neusoscience 2014), 15 - 19 Kasım 2014

24. Investigation of p53 codon 72 polymorphism and cytotoxicity in HEPG2, MCF-7 and HEK293 cell lines

Oncul S., Aydin G., Ucar G., ERCAN A.
38th Congress of the Federation-of-European-Biochemical-Societies (FEBS), Saint Peter, Guernsey Ve Alderney, 6 - 11 Temmuz 2013, cilt.280, ss.85-86, (Özet Bildiri) identifier

25. Beta amyloid fibril destabilizing activities of some pyrazoline derivatives

ERCAN A., Yabanoglu S., Gokhan-Kelekci N., Salih B., Ucar G.
35th Congress of the Federation-of-European-Biochemical-Societies, Gothenburg, İsveç, 26 Haziran - 01 Temmuz 2010, cilt.277, ss.80, (Özet Bildiri) identifier

26. Beta amyloid fibril destabilizing activities of novel monoamine oxidase (MAO) inhibitors

Yabanoglu S., ERCAN A., Kelekci-Gokhan N., Salih B., Ucar G.
34th Congress of the Federation-of-European-Biochemical-Societies, Prague, Çek Cumhuriyeti, 4 - 09 Temmuz 2009, cilt.276, ss.352, (Özet Bildiri) identifier
Metrikler

Yayın

59

Yayın (WoS)

39

Yayın (Scopus)

33

Atıf (WoS)

559

H-İndeks (WoS)

11

Atıf (Scopus)

560

H-İndeks (Scopus)

10

Proje

16

Tez Danışmanlığı

4

Açık Erişim

4
BM Sürdürülebilir Kalkınma Amaçları